Carlos Fernandez de Larrea Rodriguez

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Natalia Tovar Gomis

Institut d'Investigacions Biomèdiques August Pi i Sunyer

SPAIN

View details

Jo Caers

BELGIUM

View details

Miguel Angel Piris

SPAIN

View details

Pablo Engel

Professor

University of Barcelona

SPAIN

View details

Manuel Rodriguez-Justo

Consultant & Professor Research Pathology

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carlos Fernandez de Larrea Rodriguez

Research Interests

Explore related searches

Contact this professor

Articles (12)

Transient palindromic rheumatism induced by chimeric antigen receptor T-cell therapy

Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution

CD229 (Ly9) a Novel Biomarker for B-Cell Malignancies and Multiple Myeloma

Paraskeletal and extramedullary plasmacytomas in multiple myeloma at diagnosis and at first relapse: 50-years of experience from an academic institution

Real‐world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45‐year period

Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

Treatment of Patients with Monoclonal Gammopathy of Clinical Significance

IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation

Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy

Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

Future prospects of chimeric antigen receptor T‐cell therapy for multiple myeloma

Collaborators (5)

Natalia Tovar Gomis

Jo Caers

Miguel Angel Piris

Pablo Engel

Manuel Rodriguez-Justo

Make your next move.